FdaApplication
ANDA 210719
Identifiers
- fda_app_no: ANDA210719
Properties
| Property | Value |
|---|---|
| applicant_name | PERRIGO PHARMA INTERNATIONAL DAC |
| application_type | ANDA |
| approval_date | 2018-11-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE | 5MG;120MG | TABLET, EXTENDED RELEASE;ORAL |
1 product